Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure-Reference-Cited by-同舟云学术

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure

Published:2020-10 Issue:15 Volume:76 Page:1795-1807
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Emdin Michele,Aimo Alberto,Castiglione Vincenzo,Vergaro Giuseppe,Georgiopoulos Georgios,Saccaro Luigi Francesco,Lombardi Carlo Mario,Passino Claudio,Cerbai Elisabetta,Metra Marco,Senni Michele

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference75 articles.

1. Heart failure;Metra;Lancet,2017

2. Low urinary cGMP/BNP ratio is associated with worse outcomes in heart failure but is increased by treatment with sacubitril/valsartan: an analysis of PARADIGM-HF;Jhund;J Am Coll Cardiol,2017

3. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure;Tsutamoto;Circulation,1993

4. Mechanisms of renal hyporesponsiveness to BNP in heart failure;Egom;Can J Physiol Pharmacol,2015

5. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics;Tsai;Pharmacol Ther,2009

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the post-translational modifications in heart failure;Ageing Research Reviews;2024-09

2. Multifaced risk factors and clinical impact of a deep Y descent in patients with heart failure irrespective of RV-PA coupling;IJC Heart & Vasculature;2024-08

3. Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction;Reviews in Cardiovascular Medicine;2024-07-23

4. Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?;Heart Failure Reviews;2024-07-23

5. Eligibility for vericiguat in a real‐world, contemporary heart failure population;ESC Heart Failure;2024-07-10